TF and cancer: In cancer cells, PAR2 activation by TF/FVIIa was found to induce Akt phosphorylation and inactivation of glycogen synthase kinase-3b (GSK-3b), finally resulting in the upregulation of the Wnt pathway (Figure 3) [126,233,234].